Literature DB >> 23523462

Analysis of factors influencing the development of xerostomia during intensity-modulated radiotherapy.

Ken Randall1, Jason Stevens, Juan Fernando Yepes, Marcus E Randall, Mahesh Kudrimoti, Jonathan Feddock, Jing Xi, Richard J Kryscio, Craig S Miller.   

Abstract

OBJECTIVES: Factors influencing xerostomia during intensity-modulated radiation therapy (IMRT) were assessed.
METHODS: A 6-week study of 32 head and neck cancer (HNC) patients was performed. Subjects completed the Xerostomia Inventory (XI) and provided stimulated saliva (SS) at baseline, week 2 and at end of IMRT. Influence of SS flow rate (SSFR), calcium and mucin 5b (MUC5b) concentrations and radiation dose on xerostomia was determined.
RESULTS: HNC subjects experienced mean SSFR decline of 36% by visit 2 (N = 27; P = .012) and 57% by visit 3 (N = 20; P = .0004). Concentrations of calcium and MUC5b increased, but not significantly during IMRT (P > .05). Xerostomia correlated most with decreasing salivary flow rate as determined by Spearman correlations (P < .04) and linear mixed models (P < .0001).
CONCLUSIONS: Although IMRT is sparing to the parotid glands, it has an early effect on SSFR and the constituents in saliva in a manner that is associated with the perception of xerostomia.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23523462      PMCID: PMC3665637          DOI: 10.1016/j.oooo.2013.01.006

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  56 in total

Review 1.  Heterogeneity of high-molecular-weight human salivary mucins.

Authors:  G D Offner; R F Troxler
Journal:  Adv Dent Res       Date:  2000-12

2.  Low unstimulated salivary flow and subjective oral dryness: association with medication, anxiety, depression, and stress.

Authors:  M Bergdahl; J Bergdahl
Journal:  J Dent Res       Date:  2000-09       Impact factor: 6.116

3.  Further testing of the xerostomia inventory.

Authors:  W M Thomson; S M Williams
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2000-01

4.  A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.

Authors:  K S Chao; J O Deasy; J Markman; J Haynie; C A Perez; J A Purdy; D A Low
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-15       Impact factor: 7.038

5.  Lactoferrin, amylase and mucin MUC5B and their relation to the oral microflora in hyposalivation of different origins.

Authors:  A Almståhl; M Wikström; J Groenink
Journal:  Oral Microbiol Immunol       Date:  2001-12

6.  Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.

Authors:  A Eisbruch; H M Kim; J E Terrell; L H Marsh; L A Dawson; J A Ship
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-07-01       Impact factor: 7.038

7.  The Xerostomia Inventory: a multi-item approach to measuring dry mouth.

Authors:  W M Thomson; J M Chalmers; A J Spencer; S M Williams
Journal:  Community Dent Health       Date:  1999-03       Impact factor: 1.349

8.  Reduced sulfation of muc5b is linked to xerostomia in patients with Sjögren syndrome.

Authors:  C Alliende; Y-J Kwon; M Brito; C Molina; S Aguilera; P Pérez; L Leyton; A F G Quest; U Mandel; E Veerman; M Espinosa; H Clausen; C Leyton; R Romo; M-J González
Journal:  Ann Rheum Dis       Date:  2007-11-12       Impact factor: 19.103

9.  Microflora in oral ecosystems in subjects with radiation-induced hyposalivation.

Authors:  A Almståhl; M Wikström; B Fagerberg-Mohlin
Journal:  Oral Dis       Date:  2008-01-17       Impact factor: 3.511

10.  Effects of radiation and alpha-tocopherol on saliva flow rate, amylase activity, total protein and electrolyte levels in oral cavity cancer.

Authors:  S Chitra; C S Shyamala Devi
Journal:  Indian J Dent Res       Date:  2008 Jul-Sep
View more
  6 in total

1.  Oral and ocular late effects in head and neck cancer patients treated with radiotherapy.

Authors:  Kristine Løken Westgaard; Håvard Hynne; Bente Brokstad Herlofson; Janicke Liaaen Jensen; Cecilie Delphin Amdal; Alix Young; Preet Bano Singh; Xiangjun Chen; Morten Rykke; Lene Hystad Hove; Lara A Aqrawi; Tor P Utheim
Journal:  Sci Rep       Date:  2021-02-17       Impact factor: 4.379

2.  Saliva Metabolomics in Dry Mouth Patients with Head and Neck Cancer or Sjögren's Syndrome.

Authors:  Håvard Hynne; Elise Mørk Sandås; Katja Benedikte Prestø Elgstøen; Helge Rootwelt; Tor P Utheim; Hilde Kanli Galtung; Janicke Liaaen Jensen
Journal:  Cells       Date:  2022-01-19       Impact factor: 6.600

3.  Proteomic Profiling of Saliva and Tears in Radiated Head and Neck Cancer Patients as Compared to Primary Sjögren's Syndrome Patients.

Authors:  Håvard Hynne; Lara A Aqrawi; Janicke Liaaen Jensen; Bernd Thiede; Øyvind Palm; Cecilie Delphin Amdal; Kristine Løken Westgaard; Bente Brokstad Herlofson; Tor P Utheim; Hilde Kanli Galtung
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

4.  The effect of parotid gland-sparing intensity-modulated radiotherapy on salivary composition, flow rate and xerostomia measures.

Authors:  T M Richards; T Hurley; L Grove; K J Harrington; G H Carpenter; G B Proctor; C M Nutting
Journal:  Oral Dis       Date:  2017-06-05       Impact factor: 3.511

5.  Proteins and peptides in parotid saliva of irradiated patients compared to that of healthy controls using SELDI-TOF-MS.

Authors:  Alexa M G A Laheij; Coen N Rasch; Bernd W Brandt; Johannes J de Soet; Raymond G Schipper; Arnoud Loof; Erika Silletti; Cor van Loveren
Journal:  BMC Res Notes       Date:  2015-11-03

6.  Cytokines Explored in Saliva and Tears from Radiated Cancer Patients Correlate with Clinical Manifestations, Influencing Important Immunoregulatory Cellular Pathways.

Authors:  Lara A Aqrawi; Xiangjun Chen; Håvard Hynne; Cecilie Amdal; Sjur Reppe; Hans Christian D Aass; Morten Rykke; Lene Hystad Hove; Alix Young; Bente Brokstad Herlofson; Kristine Løken Westgaard; Tor Paaske Utheim; Hilde Kanli Galtung; Janicke Liaaen Jensen
Journal:  Cells       Date:  2020-09-08       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.